US2004250300A1PendingUtilityA1

Expression of proteins in milk

Assignee: PHARMING BVPriority: Jun 23, 1987Filed: Mar 2, 2004Published: Dec 9, 2004
Est. expiryJun 23, 2007(expired)· nominal 20-yr term from priority
Y10S530/832A01K 2227/103C12N 15/85A01K 67/0278C12N 15/8509A01K 2267/01C07K 2319/00C07K 14/4732A01K 67/0275C12N 2830/008A01K 2227/105Y10S530/833C07K 2319/02C12N 9/6456C12N 2840/44A01K 2207/15A01K 2217/00C12N 2830/85A01K 2217/05
33
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention relates to the production of recombinant proteins in mammals' milk. Particularly, this invention relates to an expression system which when transgenically incorporated into a mammal permits the female species of that mammal to produce the desired recombinant protein in or along with its milk. This invention also relates to the transgenic mammal that produces the desired recombinant product in its milk.

Claims

exact text as granted — not AI-modified
1 . Mammals' milk comprising a recombinant protein, said protein being produced along with or in said milk by the mammals.  
     
     
         2 . The milk according to  claim 1 , wherein the mammal is selected from the group consisting of cows, sheep, goats, pigs, mice, oxen and camels.  
     
     
         3 . The milk according to  claim 1 , wherein the recombinant protein is selected from the group consisting of coagulation factors VIII and IX, human or animal serum albumin, tissue plasminogen activator (TPA), urokinase, alpha-1 antitrypsin, growth hormone from animal or human sources, Mullerian Inhibiting Substance (MIS), cell surface proteins, insulin, interferons, interleukins, milk lipases, antiviral proteins, peptide hormones, immunoglobulins, lipocortin and fragments and derivatives thereof.  
     
     
         4 . A process for the production of a recombinant protein comprising the steps of collecting milk from a transgenic mammal characterized by an expression system comprising a milk-specific promoter or a promoter specifically activated in mammary tissue operatively linked to a DNA sequence coding for the recombinant protein through a DNA sequence coding for a signal peptide effective in secreting and maturing the recombinant protein in mammary tissue and isolating the recombinant protein from the milk.  
     
     
         5 . The process according to  claim 4 , wherein said expression system also includes a 3′ untranslated region downstream of the DNA sequence coding for the recombinant protein.  
     
     
         6 . The process according to  claim 4 , wherein said expression system also includes a 5′ untranslated region between said promoter and the DNA sequence coding for the signal peptide.  
     
     
         7 . A DNA sequence comprising a milk-specific promoter or a promoter specifically activated in mammary tissue operatively linked to a DNA sequence coding for a recombinant protein through a DNA sequence coding for a signal peptide effective in secreting and maturing the recombinant protein in mammary tissue.  
     
     
         8 . The DNA sequence according to  claim 7 , wherein said DNA sequence also includes a 3′ untranslated region downstream of the DNA sequence coding for the recombinant protein.  
     
     
         9 . The DNA sequence according to  claim 7 , wherein said DNA sequence also includes a 5′ untranslated region between said promoter and the DNA sequence coding for the signal peptide.  
     
     
         10 . A transgenic mammal, excluding humans, comprising a DNA sequence according to  claim 7.

Join the waitlist — get patent alerts

Track US2004250300A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.